Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward

Journal of Managed Care Pharmacy

Volumn 16, Issue 2, 2010, Pages 114-121

  Khalili, Hossein ^a   Dashti Khavidaki, Simin ^a   Talasaz, Azita Haj Hossein ^a   Tabeefar, Hamed ^a   Hendoiee, Narjes ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; OMEPRAZOLE; RANITIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CHILD; CLINICAL PRACTICE; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PHARMACIST; PRACTICE GUIDELINE; RISK FACTOR; SCHOOL CHILD; STRESS ULCER; TEACHING HOSPITAL; TREATMENT INDICATION; WARD;

EID: 77950792887     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2010.16.2.114     Document Type: Article

References (26)

1. Kleiman RL, Adair CG, Ephgrave KS. Stress ulcers: current understanding of pathogenesis and prophylaxis. Drug Intell Clin Pharm. 1988;22:452-60.
2. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000;95(11):3118-22.
3. Sesler JM. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis. AACN Adv Crit Care. 2007;18(2):119-28.
4. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994;330(6):377-81. Available at: http://content.nejm.org/cgi/content/ full/330/6/377. Accessed January 18, 2010.
5. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm. 1999;56:347-79.
6. Patel GP, Liberman J, Gurka D, Elpern E, Balk RA. Complications of critical illness: rational for prophylactic strategies. Clin Pulm Med. 2005;12(4):258-68.
7. Daley RJ, Rebuck JA, Welage LS, Rogers FB. Prevention of stress ulceration: current trends in critical care. Crit Care Med. 2004;32(10):2008-13.
8. Farrell CP, Mercogliano G, Kuntz CL. Overuse of stress ulcer prophylaxis in the critical care setting and beyond. J Crit Care. 2009 Aug. 14 (ahead of print).
9. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294(23):2989-95. Available at: http://jama.ama-assn.org/cgi/ reprint/294/23/2989. Accessed January 18, 2010.
10. Dial S, Delaney JA, Schneider V, Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ. 2006;175(7):745-58. Available at: http://www.cmaj.ca/cgi/reprint/175/7/745. Accessed January 18, 2010.
11. Pham CQ, Regal RE, Bostwick TR, Knauf KS. Acid suppressive therapy use on an inpatient internal medicine service. Ann Pharmacother. 2006;40:1261-66.
12. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009;30r (20):2120-28. Available at: http://jama.ama-assn.org/cgi/reprint/301/20/2120. Accessed January 18, 2010.
13. Dial S, Alrasadi K, Manoukian C, Huang A, Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ. 2004;171(1):33-38. Available at: http://www.cmaj.ca/cgi/reprint/171/1/33. Accessed January 18, 2010.
14. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006;101(10):2200-05.
15. Erstad BL, Barletta JF, Jacobi J, Killian AD, Kramer KM, Martin SJ. Survey of stress ulcer prophylaxis. Grit Care. 1999;3(6):145-49. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC29030/pdf/cc-3-6-145pdf. Accessed January 18, 2010.
16. Allen ME, Kopp BJ, Erstad BL. Stress ulcer prophylaxis in the postoperative period. Am J Health Syst Pharm. 2004;61(6):588-96. Abstract available at: http://www.ncbi.nlm.nih.gov/pubmed/15061430. Accessed January 13, 2010.
17. Grube RR, May DB. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm. 2007;64(13):1396-400.
18. Sung JJ. The role of acid suppression in the management and prevention of gastrointestinal hemorrhage associated with gastroduodenal ulcers. Gastroenterol Clin North Am. 2003;32(Suppl 3): S11-23.
19. Heidelbaugh JJ, Goldberg KL, Inadomi JM. Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected). Am J Gastroenterol. 2009;104(Suppl 2): S27-32.
20. Cash BD. Evidence-based medicine as it applies to acid suppression in the hospitalized patient. Crit Care Med. 2002;30(Suppl 6): S373-78.
21. Coursol CJ, Sanzari SE. Impact of stress ulcer prophylaxis algorithm study. Ann Pharmacother. 2005;39(5):810-16.
22. Mostafa G, Sing RF, Matthews B, Pratt BL, Norton HJ, Heniford BT. The economic benefit of practice guidelines for stress ulcer prophylaxis. Am Surg. 2002;68:146-50.
23. Pitimana-aree S, Forrest D, Brown G, Anis A, Wang XH, Dodek P. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med. 1998;24(3):217-23.
24. Qadeer MA, Richter JE, Brotman DJ. Hospital-acquired gastrointestinal bleeding outside the critical care unit; risk factors, role of acid suppression, and endoscopy findings. J Hosp Med. 2006;1(1):13-20.
25. Pimentel M, Roberts DE, Bernstein CN, Hoppensack M, Duerksen DR. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol. 2000;95(10):2801-06.
26. Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med. 1994;121(8):568-75. Available at: http://www.annals.org/content/121/8/568.fullpdf+html. Accessed January 18, 2010.